Author

Florian Haller

Friedrich-Alexander-Universität Erlangen-NürnbergORCID 0000-0002-0148-3273Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:variant effect prediction· 2 Assay:whole-exome sequencing· 2 Research Focus:benchmarking· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Annett HölskeniD· 2 shared Arndt HartmanniD· 2 shared Christoph SchubartiD· 2 shared Fulvia FerrazziiD· 2 shared Lars TögeliD· 2 shared Maria Giulia CartaiD· 2 shared Paolo MagniiD· 2 shared Robert StoehriD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Annett HölskenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineJournal of Molecular DiagnosticsPeer-reviewedApr 3, 2026

Oncogenicity Variant Interpreter (OncoVI): oncogenicity guidelines implementation to support somatic variants interpretation in precision oncology

Maria Giulia Carta, Lars Tögel, Annett Hölsken…·Fulvia Ferrazzi

OncoVI is a Python-based tool that automates oncogenicity classification of somatic variants using guidelines, achieving 80% accuracy on test data and 79% agreement with expert assessments.

3 citationstop 1%

humanwhole-exome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintDec 15, 2025

A fully-automated integrative workflow to streamline NGS-based analyses within Molecular Tumour Boards

Maria Giulia Carta, Miriam Angeloni, Lars Tögel…·Fulvia Ferrazzi

This paper develops a fully-automated workflow to streamline NGS-based analyses in Molecular Tumour Boards by integrating variant interpretation and biomarker estimation.

DOI 10.64898/2025.12.12.25341897

humanwhole-exome sequencing

𝕏 PostBluesky